← Eichor
Condition: Systemic Sclerosis Associated Interstitial Lung Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Systemic Sclerosis Associated Interstitial Lung Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases
NA · 1 location(s) · Oslo University Hospital · NCT06732674
Evaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung Disease
Phase N/A · 1 location(s) · Central Hospital, Nancy, France · NCT05482607
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Ass
Phase 3 · 10 location(s) · GlaxoSmithKline · NCT06716606
A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, a
Phase 2 · 4 location(s) · Changchun GeneScience Pharmaceutical Co., Ltd. · NCT06189495
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
Phase N/A · 1 location(s) · Weill Medical College of Cornell University · NCT01776398
Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT06350110
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Phase 4 · 2 location(s) · University of Sao Paulo General Hospital · NCT07087912
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Phase 2/Phase 3 · 131 location(s) · GlaxoSmithKline · NCT05878717
Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease
Phase 2 · 3 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT05785065
Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung Disease
Phase N/A · 1 location(s) · Hospital de Granollers · NCT07723872
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.